封面
市场调查报告书
商品编码
1513771

全球心房颤动设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Atrial Fibrillation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球心房颤动设备市场需求预计将从 2023 年的 109.6 亿美元达到 2032 年近 376.2 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 14.69%。

心房颤动 (AF) 设备是用于管理和治疗心房颤动的专用医疗设备,心房颤动是一种常见的心律不整,其特征是心率不规则且通常较快。心房颤动设备包括心律调节器、植入式心律转復除颤器 (ICD) 和导管消融系统。心律调节器透过向心臟发送电脉衝来帮助调节心律,而 ICD 可以透过提供电击来检测和纠正异常心律。导管消融涉及使用能量破坏导致 AF 的心臟组织小区域。这些设备透过减少心房颤动患者的症状、预防併发症和提高生活质量,显着改善患者的治疗效果。

市场动态

由于心房颤动 (AF) 盛行率不断上升,特别是在老龄化人口中,心房颤动设备市场正在经历强劲增长,导致对有效管理解决方案的需求更高。医疗技术的进步也发挥了关键作用,促进了创新型心房颤动设备的开发,提高了准确性、安全性和患者治疗效果。这些技术进步包括下一代心律调节器、导管消融系统和植入式心律转復除颤器 (ICD),显着增强了 AF 治疗。此外,人们对未经治疗的心房颤动(如中风和心臟衰竭)相关风险的认识不断提高,鼓励更多患者寻求治疗,从而促进市场成长。此外,支持性政府政策和增加的医疗保健支出有助于更好地获得先进的心房颤动治疗选择。然而,心房颤动设备的高成本以及发展中地区获得先进医疗保健的机会有限可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球心房颤动设备市场的各个细分市场进行了包容性评估。心房颤动设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

心房颤动设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • EP消融导管
  • EP 诊断导管
  • 测绘和记录系统
  • 心臟监测仪或植入式循环记录仪
  • 存取装置
  • 心内超音波心动图(ICE)
  • 左心耳 (LAA) 封堵器

按最终用途

  • 医院
  • 心臟中心
  • 门诊手术中心
  • 其他的

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的心房颤动设备市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心房颤动设备市场的主要参与者包括雅培实验室、强生公司、Atricure Inc.、Microport Scientific Corporation、Boston Scientific Corporation、St. Jude Medical Inc、Medtronic Plc、Koninklijke Philips NV、Siemens AG。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:心房颤动设备 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球心房颤动设备市场分析:依产品分类

  • 概述(按产品)
  • 按产品分类的历史和预测资料分析
  • EP消融导管
  • EP 诊断导管
  • 测绘和记录系统
  • 心臟监测仪或植入式循环记录仪
  • 存取装置
  • 心内超音波心动图(ICE)
  • 左心耳 (LAA) 封堵器

第 6 章:全球心房颤动设备市场分析:依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院
  • 心臟中心
  • 门诊手术中心
  • 其他的

第 7 章:全球心房颤动设备市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:心房颤动设备公司的竞争格局

  • 心房颤动设备市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Abbott Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Johnson & Johnson
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Atricure Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Microport Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Boston Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • St. Jude Medical Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medtronic Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Koninklijke Philips NV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中,财务详细资料和最新进展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR112115079

The global demand for Atrial Fibrillation Devices Market is presumed to reach the market size of nearly USD 37.62 Billion by 2032 from USD 10.96 Billion in 2023 with a CAGR of 14.69% under the study period 2024-2032.

Atrial fibrillation (AF) devices are specialized medical devices used to manage and treat atrial fibrillation, a common cardiac arrhythmia characterized by irregular and often rapid heart rate. Atrial fibrillation devices include pacemakers, implantable cardioverter defibrillators (ICDs), and catheter ablation systems. Pacemakers help regulate heart rhythms by sending electrical impulses to the heart, while ICDs can detect and correct abnormal rhythms by delivering shocks. Catheter ablation involves using energy to destroy small areas of heart tissue that cause AF. These devices significantly improve patient outcomes by reducing symptoms, preventing complications, and enhancing the quality of life for those with atrial fibrillation.

MARKET DYNAMICS

The atrial fibrillation devices market is experiencing robust growth fuelled by the rising prevalence of atrial fibrillation (AF), particularly among the aging population, leading to a higher demand for effective management solutions. Progress in medical technology has also had a pivotal role, resulting in the development of innovative atrial fibrillation devices that offer improved accuracy, safety, and patient outcomes. These technological advancements include next-generation pacemakers, catheter ablation systems, and implantable cardioverter defibrillators (ICDs), significantly enhancing AF treatment. Furthermore, the rising awareness about the risks associated with untreated atrial fibrillation, such as stroke and heart failure, is encouraging more patients to seek treatment, thereby boosting market growth. Additionally, supportive government policies and increasing healthcare expenditure facilitate better access to advanced AF treatment options. However, the high cost of atrial fibrillation devices and limited access to advanced healthcare in developing regions may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Atrial Fibrillation Devices. The growth and trends of Atrial Fibrillation Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Atrial Fibrillation Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • EP Ablation Catheters
  • EP Diagnostic Catheters
  • Mapping and Recording Systems
  • Cardiac Monitors or Implantable Loop Recorder
  • Access Devices
  • Intracardiac Echocardiography (ICE)
  • Left Atrial Appendage (LAA) Closure Devices

By End-use

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Atrial Fibrillation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Atrial Fibrillation Devices market include Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, Boston Scientific Corporation, St. Jude Medical Inc, Medtronic Plc, Koninklijke Philips N.V., Siemens AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ATRIAL FIBRILLATION DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. EP Ablation Catheters Historic and Forecast Sales By Regions
  • 5.4. EP Diagnostic Catheters Historic and Forecast Sales By Regions
  • 5.5. Mapping and Recording Systems Historic and Forecast Sales By Regions
  • 5.6. Cardiac Monitors or Implantable Loop Recorder Historic and Forecast Sales By Regions
  • 5.7. Access Devices Historic and Forecast Sales By Regions
  • 5.8. Intracardiac Echocardiography (ICE) Historic and Forecast Sales By Regions
  • 5.9. Left Atrial Appendage (LAA) Closure Devices Historic and Forecast Sales By Regions

6. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data Analysis By End-use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Centers Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ATRIAL FIBRILLATION DEVICES COMPANIES

  • 8.1. Atrial Fibrillation Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF ATRIAL FIBRILLATION DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Johnson & Johnson
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Atricure Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Microport Scientific Corporation
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Boston Scientific Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. St. Jude Medical Inc
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medtronic Plc
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Koninklijke Philips N.V.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Siemens AG
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • EP Ablation Catheters Market Sales By Geography (USD MN)
  • EP Diagnostic Catheters Market Sales By Geography (USD MN)
  • Mapping and Recording Systems Market Sales By Geography (USD MN)
  • Cardiac Monitors or Implantable Loop Recorder Market Sales By Geography (USD MN)
  • Access Devices Market Sales By Geography (USD MN)
  • Intracardiac Echocardiography (ICE) Market Sales By Geography (USD MN)
  • Left Atrial Appendage (LAA) Closure Devices Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Atrial Fibrillation Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Atrial Fibrillation Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Atrial Fibrillation Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • EP Ablation Catheters Market Sales By Geography (USD MN)
  • EP Diagnostic Catheters Market Sales By Geography (USD MN)
  • Mapping and Recording Systems Market Sales By Geography (USD MN)
  • Cardiac Monitors or Implantable Loop Recorder Market Sales By Geography (USD MN)
  • Access Devices Market Sales By Geography (USD MN)
  • Intracardiac Echocardiography (ICE) Market Sales By Geography (USD MN)
  • Left Atrial Appendage (LAA) Closure Devices Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.